Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

This publication has 11 references indexed in Scilit:

• A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
  British Journal of Cancer, 1999
• Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck
  Annals of Oncology, 1999
• Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck
  Annals of Oncology, 1997
• Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
  Journal of Clinical Oncology, 1996
• Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
  Journal of Clinical Oncology, 1992
• A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
  British Journal of Cancer, 1990
• Reporting results of cancer treatment
  Cancer, 1981
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958